PrEP reminds me that I am the one to take responsibility of my life: a qualitative study exploring experiences of and attitudes towards pre-exposure prophylaxis use by women in Eswatini.
Eswatini
HIV
Pre-exposure prophylaxis
Qualitative research
Self care
Women
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
14 04 2021
14 04 2021
Historique:
received:
12
01
2021
accepted:
30
03
2021
entrez:
15
4
2021
pubmed:
16
4
2021
medline:
25
5
2021
Statut:
epublish
Résumé
Pre-exposure-prophylaxis (PrEP) has been heralded for its potential to put women in control of preventing HIV infection, but uptake and continuation rates have been disappointing in high-incidence settings in sub-Saharan Africa. We explored structural and social factors that influenced PrEP use among young women and pregnant or breastfeeding women in rural Eswatini. We conducted two in-depth interviews with ten women on PrEP, and one-time in-depth interviews with fourteen women who declined or discontinued PrEP. Interviews covered decision-making processes around PrEP initiation and experiences with pill-taking. In-depth interviews were conducted with nine health workers, covering experiences in delivering PrEP services, and two focus group discussions were held with men to elicit their perceptions of PrEP. Interviews and discussions were audio-recorded, translated, transcribed and analysed thematically, using an inductive approach. PrEP initiation and use were experienced by many women as empowering them to take control of their health and well-being, and stay HIV free, facilitating them to realise their aspirations relating to motherhood and educational attainment. However, the social norms that defined relationship dynamics with partners or family members either undermined or promoted this empowerment potential. In particular, young women were rarely supported by family members to take PrEP unless it was perceived to be for protecting an unborn child. Stigmatisation of pill-taking through its associations with HIV and the burden of daily pill-taking also contributed to PrEP discontinuation. Unlike many prevention tools, PrEP enabled women to achieve a sense of control over their lives. Nevertheless, women's agency to continue and adhere to PrEP was influenced by social and structural factors including gender norms, family expectations of young women, relationship dynamics and stigma related to HIV. Future interventions should address these barriers to promote PrEP use among sexually-active women.
Sections du résumé
BACKGROUND
Pre-exposure-prophylaxis (PrEP) has been heralded for its potential to put women in control of preventing HIV infection, but uptake and continuation rates have been disappointing in high-incidence settings in sub-Saharan Africa. We explored structural and social factors that influenced PrEP use among young women and pregnant or breastfeeding women in rural Eswatini.
METHODS
We conducted two in-depth interviews with ten women on PrEP, and one-time in-depth interviews with fourteen women who declined or discontinued PrEP. Interviews covered decision-making processes around PrEP initiation and experiences with pill-taking. In-depth interviews were conducted with nine health workers, covering experiences in delivering PrEP services, and two focus group discussions were held with men to elicit their perceptions of PrEP. Interviews and discussions were audio-recorded, translated, transcribed and analysed thematically, using an inductive approach.
RESULTS
PrEP initiation and use were experienced by many women as empowering them to take control of their health and well-being, and stay HIV free, facilitating them to realise their aspirations relating to motherhood and educational attainment. However, the social norms that defined relationship dynamics with partners or family members either undermined or promoted this empowerment potential. In particular, young women were rarely supported by family members to take PrEP unless it was perceived to be for protecting an unborn child. Stigmatisation of pill-taking through its associations with HIV and the burden of daily pill-taking also contributed to PrEP discontinuation.
CONCLUSIONS
Unlike many prevention tools, PrEP enabled women to achieve a sense of control over their lives. Nevertheless, women's agency to continue and adhere to PrEP was influenced by social and structural factors including gender norms, family expectations of young women, relationship dynamics and stigma related to HIV. Future interventions should address these barriers to promote PrEP use among sexually-active women.
Identifiants
pubmed: 33853575
doi: 10.1186/s12889-021-10766-0
pii: 10.1186/s12889-021-10766-0
pmc: PMC8048211
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
727Références
Infect Dis Ther. 2017 Sep;6(3):363-382
pubmed: 28600755
J Infect Dis. 2018 Jun 5;218(1):16-25
pubmed: 29514254
J Int AIDS Soc. 2019 Jan;22(1):e25225
pubmed: 30657642
J Int AIDS Soc. 2020 Jun;23(6):e25528
pubmed: 32544303
AIDS Patient Care STDS. 2016 Feb;30(2):78-83
pubmed: 26836236
Am J Public Health. 2007 Jan;97(1):13-8
pubmed: 17138923
Cult Health Sex. 2020 Jul 7;:1-17
pubmed: 32633617
BMC Med. 2020 Jul 7;18(1):189
pubmed: 32631314
AIDS. 2019 Jun 1;33 Suppl 1:S45-S52
pubmed: 31397722
J Int AIDS Soc. 2015 Jul 20;18(4 Suppl 3):19983
pubmed: 26198346
J Acquir Immune Defic Syndr. 2018 Dec 15;79(5):580-589
pubmed: 30239426
Cult Health Sex. 2021 Feb;23(2):257-272
pubmed: 32129720
J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):606-608
pubmed: 27846073
Lancet HIV. 2017 Feb;4(2):e83-e92
pubmed: 27863998
J Infect Dis. 2018 Jun 5;218(1):1-4
pubmed: 29506075
Open AIDS J. 2018 Jul 19;12:53-67
pubmed: 30123385
J Acquir Immune Defic Syndr. 2019 Apr 15;80(5):542-550
pubmed: 30865050
J Int AIDS Soc. 2019 Apr;22(4):e25276
pubmed: 31037845
AIDS. 2016 Jul 31;30(12):1973-83
pubmed: 27149090
AIDS Behav. 2018 Feb;22(2):447-453
pubmed: 27943000
AIDS Care. 2019 Jun;31(6):660-666
pubmed: 30309246
J Int AIDS Soc. 2016 Oct 18;19(7(Suppl 6)):21107
pubmed: 27760684